176 related articles for article (PubMed ID: 17823119)
1. A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis.
Gibb SL; Boston-Howes W; Lavina ZS; Gustincich S; Brown RH; Pasinelli P; Trotti D
J Biol Chem; 2007 Nov; 282(44):32480-90. PubMed ID: 17823119
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2.
Foran E; Bogush A; Goffredo M; Roncaglia P; Gustincich S; Pasinelli P; Trotti D
Glia; 2011 Nov; 59(11):1719-31. PubMed ID: 21769946
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS.
Rosenblum LT; Shamamandri-Markandaiah S; Ghosh B; Foran E; Lepore AC; Pasinelli P; Trotti D
Exp Neurol; 2017 Jun; 292():145-153. PubMed ID: 28342750
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.
Foran E; Rosenblum L; Bogush A; Pasinelli P; Trotti D
Glia; 2014 Aug; 62(8):1241-53. PubMed ID: 24753081
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2.
Boston-Howes W; Gibb SL; Williams EO; Pasinelli P; Brown RH; Trotti D
J Biol Chem; 2006 May; 281(20):14076-84. PubMed ID: 16567804
[TBL] [Abstract][Full Text] [Related]
7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
8. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
9. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
10. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1.
Warita H; Manabe Y; Murakami T; Shiote M; Shiro Y; Hayashi T; Nagano I; Shoji M; Abe K
Neurol Res; 2002 Sep; 24(6):577-81. PubMed ID: 12238624
[TBL] [Abstract][Full Text] [Related]
11. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
[TBL] [Abstract][Full Text] [Related]
12. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
[TBL] [Abstract][Full Text] [Related]
14. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
16. Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment.
Jiang LL; Zhu B; Zhao Y; Li X; Liu T; Pina-Crespo J; Zhou L; Xu W; Rodriguez MJ; Yu H; Cleveland DW; Ravits J; Da Cruz S; Long T; Zhang D; Huang TY; Xu H
J Clin Invest; 2019 May; 129(8):3103-3120. PubMed ID: 31112137
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
[TBL] [Abstract][Full Text] [Related]
18. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
19. Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.
Morel L; Regan M; Higashimori H; Ng SK; Esau C; Vidensky S; Rothstein J; Yang Y
J Biol Chem; 2013 Mar; 288(10):7105-16. PubMed ID: 23364798
[TBL] [Abstract][Full Text] [Related]
20. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
